Artykuły udostępnione publicznie: - Priscilla BrastianosWięcej informacji
OgółemNIHDamon Runyon Cancer Research FoundationSusan G. KomenAmerican Brain Tumor AssociationDoDCIHRDFGMelanoma Research AllianceHHMIWellcomeEuropean CommissionV Foundation, USAGovernment of SpainBrain Tumour Charity, UKHFSPNSFSNSFFWFCCSHelmholtzRCNCZIGatesVANHMRCGenome CanadaHRBSwedish Research CouncilVersus Arthritis, UKCancer Research UKMRCNIHRWorldwide Cancer Research, UKDoris Duke Charitable FoundationBMBFKWFCPRITRoyal Society UKOICR
Niedostępne w żadnym miejscu: 11
Advances in meningioma genetics: novel therapeutic opportunities
M Preusser, PK Brastianos, C Mawrin
Nature Reviews Neurology 14 (2), 106-115, 2018
Upoważnienia: German Research Foundation
Single-arm, open-label phase 2 trial of pembrolizumab in patients with leptomeningeal carcinomatosis
PK Brastianos, EQ Lee, JV Cohen, SM Tolaney, NU Lin, N Wang, ...
Nature medicine 26 (8), 1280-1284, 2020
Upoważnienia: US National Institutes of Health, Damon Runyon Cancer Research Foundation …
Understanding the activity of antibody–drug conjugates in primary and secondary brain tumours
MJ Mair, R Bartsch, E Le Rhun, AS Berghoff, PK Brastianos, J Cortes, ...
Nature Reviews Clinical Oncology 20 (6), 372-389, 2023
Upoważnienia: US National Institutes of Health, Austrian Science Fund
Increased risk of brain metastases in ovarian cancer patients with BRCA mutations
E Ratner, M Bala, M Louie-Gao, E Aydin, S Hazard, PK Brastianos
Gynecologic Oncology 153 (3), 568-573, 2019
Upoważnienia: US National Institutes of Health, Damon Runyon Cancer Research Foundation …
New molecular targets in meningiomas: the present and the future
VA Venur, S Santagata, E Galanis, PK Brastianos
Current opinion in neurology 31 (6), 740-746, 2018
Upoważnienia: Damon Runyon Cancer Research Foundation, American Brain Tumor Association …
Implementation of TERT promoter mutations improve prognostication of the WHO classification in meningioma
C Mirian, K Grell, TA Juratli, F Sahm, S Spiegl‐Kreinecker, M Peyre, ...
Neuropathology and Applied Neurobiology 48 (3), e12773, 2022
Upoważnienia: US Department of Defense, US National Institutes of Health
Central nervous system metastases
E Nieblas-Bedolla, J Zuccato, H Kluger, G Zadeh, PK Brastianos
Hematology/Oncology Clinics 36 (1), 161-188, 2022
Upoważnienia: Damon Runyon Cancer Research Foundation
Anatomy-oriented stereotactic approach to cerebrospinal fluid collection in mice
K Shimizu, A Gupta, PK Brastianos, H Wakimoto
Brain Research 1774, 147706, 2022
Upoważnienia: US National Institutes of Health, Damon Runyon Cancer Research Foundation
Initial approach to the patient with multiple newly diagnosed brain metastases
CK Starkweather, BD Choi, C Alvarez-Breckenridge, PK Brastianos, K Oh, ...
Neurosurgery Clinics 31 (4), 505-513, 2020
Upoważnienia: US National Institutes of Health
Biology and pathophysiology of central nervous system metastases
M Singh, A Dahal, M de Sauvage, J Larson, PK Brastianos
Neurological Complications of Systemic Cancer and Antineoplastic Therapy, 55-78, 2022
Upoważnienia: US National Institutes of Health, Damon Runyon Cancer Research Foundation
Atypical and Malignant Meningiomas
BA Castro, MMJ Chua, PK Brastianos
Textbook of Uncommon Cancer, 856-870, 2017
Upoważnienia: US National Institutes of Health, Howard Hughes Medical Institute, Susan G …
Dostępne w jakimś miejscu: 113
An integrative model of cellular states, plasticity, and genetics for glioblastoma
C Neftel, J Laffy, MG Filbin, T Hara, ME Shore, GJ Rahme, AR Richman, ...
Cell 178 (4), 835-849. e21, 2019
Upoważnienia: Swiss National Science Foundation, US National Institutes of Health, Howard …
Genomic characterization of brain metastases reveals branched evolution and potential therapeutic targets
PK Brastianos, SL Carter, S Santagata, DP Cahill, A Taylor-Weiner, ...
Cancer discovery 5 (11), 1164-1177, 2015
Upoważnienia: US National Institutes of Health, Susan G. Komen
Decoupling genetics, lineages, and microenvironment in IDH-mutant gliomas by single-cell RNA-seq
AS Venteicher, I Tirosh, C Hebert, K Yizhak, C Neftel, MG Filbin, ...
Science 355 (6332), eaai8478, 2017
Upoważnienia: US National Institutes of Health, Howard Hughes Medical Institute, Wellcome …
Genomic sequencing of meningiomas identifies oncogenic SMO and AKT1 mutations
PK Brastianos, PM Horowitz, S Santagata, RT Jones, A McKenna, G Getz, ...
Nature genetics 45 (3), 285-289, 2013
Upoważnienia: US National Institutes of Health
Exome sequencing identifies BRAF mutations in papillary craniopharyngiomas
PK Brastianos, A Taylor-Weiner, PE Manley, RT Jones, D Dias-Santagata, ...
Nature genetics 46 (2), 161-165, 2014
Upoważnienia: US National Institutes of Health
Longitudinal molecular trajectories of diffuse glioma in adults
FP Barthel, KC Johnson, FS Varn, AD Moskalik, G Tanner, E Kocakavuk, ...
Nature 576 (7785), 112-120, 2019
Upoważnienia: US National Institutes of Health, Austrian Science Fund, National Health and …
Analysis of tumour-and stroma-supplied proteolytic networks reveals a brain-metastasis-promoting role for cathepsin S
L Sevenich, RL Bowman, SD Mason, DF Quail, F Rapaport, BT Elie, ...
Nature cell biology 16 (9), 876-888, 2014
Upoważnienia: US National Institutes of Health, Canadian Institutes of Health Research …
Brain metastasis
A Boire, PK Brastianos, L Garzia, M Valiente
Nature Reviews Cancer 20 (1), 4-11, 2020
Upoważnienia: Canadian Cancer Society, Canadian Institutes of Health Research, Worldwide …
Pervasive chromosomal instability and karyotype order in tumour evolution
TBK Watkins, EL Lim, M Petkovic, S Elizalde, NJ Birkbak, GA Wilson, ...
Nature 587 (7832), 126-132, 2020
Upoważnienia: US Department of Defense, US National Institutes of Health, Helmholtz …
Informacje na temat publikacji i finansowania automatycznie określa program komputerowy